Jackson Creek Investment Advisors LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 696 shares of the biopharmaceutical company’s stock after selling 76 shares during the quarter. Jackson Creek Investment […]